Redhill Biopharma
RDHL
#10205
Rank
โ‚น0.37 B
Marketcap
โ‚น290.80
Share price
-7.50%
Change (1 day)
-74.02%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2023 (TTM): โ‚น0.96 Billion

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚น35.74 Million. In 2022 the company made an earning of -โ‚น6.26 Billion, an increase over its 2021 earnings that were of -โ‚น8.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) โ‚น0.96 B-115.49%
2022 -โ‚น6.26 Billion-26.68%
2021 -โ‚น8.54 Billion28.32%
2020 -โ‚น6.66 Billion80.06%
2019 -โ‚น3.7 Billion8.97%
2018 -โ‚น3.4 Billion-14.76%
2017 -โ‚น3.98 Billion55.07%
2016 -โ‚น2.57 Billion39.26%
2015 -โ‚น1.85 Billion96.9%
2014 -โ‚น0.94 Billion0.78%
2013 -โ‚น0.93 Billion16.93%
2012 -โ‚น0.8 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น693.55 B 68,531.52%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น1.307 T 129,289.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น364.22 B 35,942.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น3.81 B 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚น24.63 Billion-2,536.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel